Do Nicotine Pouches Help You Quit Smoking?
There is very little evidence that nicotine pouches help people stop smoking. A 2025 Cochrane review found only four small trials covering 284 people in total, three of them at high risk of bias, and rated the findings very low certainty. Pouches are not licensed as stop-smoking aids anywhere.
That is a different answer from the one most retailer websites give, and it is worth being precise about what it means. “Very little evidence” is not the same as “does not work”. It means researchers have not yet run the studies that would tell us either way, and the small amount of work done so far is not good enough to draw conclusions from.
What the Research Actually Found
The most authoritative assessment is a Cochrane systematic review published in 2025 by Hartmann-Boyce and colleagues, which searched the major medical databases for every randomised controlled trial of oral nicotine pouches conducted since 2000.
| What it found | Detail |
|---|---|
| Trials identified | 4, all in people who smoked cigarettes at baseline |
| Total participants | 284 across all four studies, none with more than 150 |
| Study length | Between one and eight weeks |
| Risk of bias | Three rated high risk, one unclear |
| Funding | Three independently funded, one funded by a manufacturer |
| Locations | Three in the USA, one in New Zealand |
On the central question of quitting, one trial compared pouches against no intervention and found slightly higher abstinence at eight weeks. That trial had 27 participants. The confidence interval around the result ran from 0.07 to 35.32, a range so wide it includes the possibility of substantial benefit, no effect at all, and harm. Cochrane rated it very low certainty, which is the lowest rating available.
A second finding matters more. One small study compared pouches directly against nicotine e-cigarettes, and people using pouches were slightly less likely to quit. That is low-certainty evidence from a single study, so it should not be treated as settled either, but it points in the opposite direction from the marketing.
The review also found no evidence at all on using pouches to stop other tobacco or nicotine products, so if you are looking to move off vaping or traditional snus, there is nothing to go on.
How That Compares to Vaping and Licensed NRT
The contrast with the neighbouring evidence base is stark.
Cochrane’s review of e-cigarettes for smoking cessation was updated on 26 August 2026 and now covers 80 randomised trials with 29,861 participants. It found that nicotine e-cigarettes help more people quit than nicotine replacement therapy, rated high-certainty evidence, among the strongest ratings Cochrane issues. Against behavioural support alone, quit rates were higher again.
Licensed nicotine replacement therapy, patches, gum, lozenges, sprays and inhalators, has decades of trial data behind it and regulatory approval as a medicine.
This does not prove pouches are ineffective. It means that if your goal is stopping smoking and you want to follow the evidence, two options have it and pouches do not yet.
What Pouches Do Appear to Do
The review found something more solid on exposure than on quitting.
Biomarker data showed lower carbon monoxide and lower tobacco-specific nitrosamine levels in people using pouches compared with people smoking cigarettes. That is unsurprising, those compounds come from combustion, and there is no combustion in a pouch, but it was measured rather than assumed. Cochrane rated it low-certainty evidence of reduced toxicant exposure.
Reduced exposure to specific toxicants is not the same as being safe or being healthy. Nicotine remains addictive regardless of how it is delivered, and the long-term effects of pouch use are not established, because the products have not existed long enough for that research to be done.
On short-term safety, the three trials that reported serious adverse events found none. Side effects were mild and were the ones regular users would recognise: nausea and mouth irritation.
Why the Evidence Is So Thin
Nicotine pouches reached mainstream markets around 2019 to 2021. Cessation trials take years to design, run, follow up and publish, and the trials that exist were mostly one to eight weeks long, which is far too short to measure sustained quitting, the standard outcome in this field is abstinence at six or twelve months.
There is also a funding problem. Pharmaceutical companies fund NRT trials because they sell licensed medicines. Nobody has the same incentive to fund independent pouch cessation research, and manufacturer-funded studies carry obvious interpretive problems. The Cochrane authors explicitly called for larger, longer, independent studies.
Expect this answer to change. It has not changed yet.
Pouches Are Not a Licensed Stop-Smoking Product
This is a regulatory fact rather than an opinion, and it is worth understanding because it explains a lot of what you will read elsewhere.
Licensed nicotine replacement therapy has been assessed by medicines regulators for safety and efficacy in helping people stop smoking. That licence is why a pharmacist can recommend a patch for that purpose.
If You Want to Stop Smoking
The options with the strongest evidence behind them are licensed NRT, prescription medication, and nicotine vaping, and all of them work substantially better when combined with behavioural support. Local stop smoking services provide that support free in most countries and roughly double the odds of success compared with going it alone. A GP or pharmacist is the practical starting point.
If you are going to use pouches anyway, and plenty of people do, a few things follow from what is known.
- Match the strength to your smoking: Heavy smokers typically need 6mg to 10mg per pouch, and the very high strength products are aimed at established pouch users, not people arriving from cigarettes.
- Understand what you are switching: You are changing nicotine sources, not ending nicotine use — the tobacco-free pouch category is addictive on its own terms.
- If reducing intake is the eventual goal: Stepping down through lower strengths and then to nicotine-free pouches is the route people generally take, though there is no trial evidence on how well that works either.
Frequently Asked Questions
Do nicotine pouches help you quit smoking?
The evidence is too limited to say. A 2025 Cochrane review found only four small trials with 284 participants in total, three at high risk of bias, and rated the results very low certainty. One trial found pouches slightly less effective than nicotine e-cigarettes for quitting.
Are nicotine pouches better than patches for quitting?
There is no good evidence that they are. Patches and other licensed nicotine replacement therapies have decades of trial data and regulatory approval as stop-smoking medicines. Nicotine pouches have four short trials and no licence for that purpose in any market.
Are nicotine pouches safer than cigarettes?
Trial biomarker data showed lower carbon monoxide and nitrosamine levels in pouch users compared with smokers, which Cochrane rated low-certainty evidence of reduced toxicant exposure. That is not the same as safe. Nicotine is addictive, and the long-term effects of pouch use are not yet established.
What strength pouch should a smoker start with?
There is no clinical guidance, since pouches are not licensed cessation products. In practice, people moving from a heavy smoking habit tend to start between 6mg and 10mg per pouch. Very high strength products are aimed at established pouch users and are a common cause of nausea in newcomers.
Can nicotine pouches help you quit vaping or snus?
The Cochrane review found no evidence at all on using pouches to stop other tobacco or nicotine products. Every trial identified involved people who smoked cigarettes at baseline, so nothing in the research addresses switching from vaping, snus or any other source.
Why do retailers say pouches help you quit?
Because retailers are not bound by the rules that apply to manufacturers. Marketing a product as a smoking cessation treatment would make it an unlicensed medicine, which is why brands themselves avoid the claim. Retailer cessation claims are not supported by the trial evidence.